This article is more than 5 years old. Information may no longer be current.

ASCO elects 2016 president

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Daniel F. Hayes, MD, FASCO, will serve as president of ASCO for the term beginning in June 2016.

He will become president-elect during the society’s annual meeting in June 2015.

Daniel F. Hayes

“I’m honored to be elected incoming president of ASCO, which has had such a major influence on my professional career,” Hayes said in a press release. “I look forward to working with ASCO leadership and staff on the critical initiatives within the oncology community, including new strategies for health care reform; the development of CancerLinQ; efforts to improve value in cancer care; personalized cancer care; and reducing global disparities in cancer treatment.”

Hayes, a breast cancer specialist, is a professor of internal medicine, the Stuart B. Padnos professor in breast cancer and clinical director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. He has been a member of ASCO since 1986 and served on its board of directors from 2011-2014.

ASCO also elected four new members of its board of directors:

• Craig R. Nichols, MD, co-director of the Testicular Cancer Multidisciplinary Clinic at Virginia Mason Medical Center in Seattle, will serve as treasurer.
• J. Chris Nunnink, MD, FASCO, has been elected to a community oncologist seat. Nunnink is an attending physician in medical oncology at Fletcher Allen Health Care, and an associate professor at Vermont Cancer Center and the College of Medicine at the University of Vermont.
• Stephen B. Edge, MD, FASCO, has been elected to a surgical oncologist seat. Edge is director of the Baptist Cancer Center and adjunct professor of surgery at Vanderbilt University School of Medicine.
• Jedd D. Wolchok, MD, PhD, has been elected to an undesignated specialty seat. Wolchok is chief of melanoma and immunotherapeutics services and associate director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center. He also is a HemOnc Today Editorial Board member.